OcNOS® Open Networking Upgrade Delivers Significant Bandwidth Boost and Cost Efficiency for an Alpine Provider
Santa Clara, CA – December 11, 2025 – IP Infusion, a global leader in open networking software solutions, today announced that eww ITandTEL, one of Austria's premier IT and telecommunications value-added service providers, has upgraded its MPLS backbone using IP Infusion's OcNOS-SP-PLUS. The upgrade advances the operator from 100G to a future-ready 400G IP over DWDM (IPoDWDM) architecture.
With more than 30 years of experience operating secure data centers and extensive fiber infrastructure, eww ITandTEL required a solution that could scale with customer demand while optimizing costs. By replacing legacy constraints with an open networking model, eww ITandTEL has successfully deployed 400G ZR+ coherent transceiver-based circuits across a multi-vendor environment.
"Reliability and performance are non-negotiable for our customers, and that drives every architectural choice we make," said Christoph Ehmayer, 네트워크/시스템 엔지니어 팀 리드, eww ITandTEL. "OcNOS 기반의 개방형 400G IPoDWDM 백본으로의 전환은, 서비스를 지속적으로 안정적으로 운영하고 수요에 앞서 나가기 위해 필요한 제어성, 가시성, 운영 효율을 제공합니다."
The new backbone is powered by OcNOS running on high-performance whitebox platforms from UfiSpace (S9600-56DX, S9510-28DC) and Edgecore (AS7946-30XB). This disaggregated approach maximizes bandwidth and resiliency while avoiding traditional vendor lock-in associated with legacy chassis systems.
"This upgrade is part of our commitment to deliver the very best digital infrastructure in the region—high-capacity, sovereign, and built for long-term growth," said Roland Neumayr, Head of Network/Datacenter, eww ITandTEL. "By adopting open networking, we're ensuring that our customers benefit from a network that is both faster and strategically prepared for the future."
"eww ITandTEL is a perfect example of how forward-thinking regional providers can outpace the competition by embracing open networking," said Tom Savoie, CEO of IP Infusion. "By decoupling software from hardware, we are empowering them to build a network that is more robust, less expensive to operate, and agile enough to adapt to future needs. We are proud to support their mission of delivering sovereign, reliable data services in Austria."
EPS Global, a respected value-added distributor and system-integration partner, played a key role in enabling this upgrade. With its global distribution network, technical services, and supply-chain logistics, EPS Global ensured that all necessary components were sourced, configured, and delivered on schedule.
IP Infusion 소개
IP Infusion develops open network software solutions for carriers, service providers, and data centers. With hundreds of customers and thousands of deployments, IP Infusion leads the market in Network Operating Systems. Its flagship platform, OcNOS®, empowers network operators to disaggregate their networks, streamline operations, and reduce total cost of ownership (TCO). Headquartered in Santa Clara, Calif., IP Infusion is a wholly owned subsidiary of ACCESS CO., LTD. For more information, visit www.ipinfusion.com/.
About eww ITandTEL
eww ITandTEL delivers end-to-end IT services made in Austria, including high-performance networks, Internet services, data center housing and hosting, backup and disaster recovery solutions, cloud infrastructure, and cybersecurity services. With proprietary data center locations certified by ISO/IEC 27001 and EN 50600 standards, and a Europe-wide backbone network – directly connected to Europe's major Internet hubs. A decisive added value is always included: your personal contact always at your side.
Media Contact:
Katherine Verducci, 1903 PR
kverducci@1903pr.com
408.429.5779
IP Infusion 소개
IP Infusion은 오픈 네트워킹 소프트웨어의 선도적 공급업체로서, 서비스 프로바이더, 데이터센터, AI 패브릭 네트워크를 위한 캐리어급 네트워크 운영체제인 OcNOS를 제공합니다. 26+ 년의 네트워킹 전문성과 전 세계 600+ 오퍼레이터 실적을 바탕으로, Edgecore Networks, UfiSpace, Celestica 등 파트너의 검증된 오픈 하드웨어에서 개방적이고 멀티벤더이며 비용 효율적이고 유연한 네트워크 인프라를 구현합니다. IP Infusion은 ACCESS CO., LTD.(도쿄증권거래소: 4813)의 완전 자회사입니다.
미디어 문의
For press inquiries, analyst briefings, or media materials, please 팀에 문의 or email pr@ipinfusion.com.
미래예측 진술
본 보도자료에는 IP Infusion의 제품, 기술 및 계획에 관한 미래예측 진술이 포함될 수 있습니다. 미래예측 진술은 공개일 현재 이용 가능한 정보에 기초하며 위험과 불확실성을 수반합니다. 실제 결과는 다를 수 있습니다. 제품 계획, 기능, 출시 시기 및 제공 여부는 예고 없이 변경될 수 있으며 약정, 약속 또는 법적 의무를 구성하지 않습니다. IP Infusion은 미래예측 진술을 갱신할 의무를 지지 않습니다.